VC and Investment
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Today's issue
Refine Search
Biotechnology
San Francisco, USA-based biotech start-up Kivu Bioscience has announced the closing of a $92 million Series A financing round led by Novo Holdings, which as of year-end 2011123 had total assets of 149 billion euros ($161 billion). 28 October 2024
Biotechnology
Ottimo Pharma, a biotech founded by Medicxi in 2020, has emerged from stealth mode with an executive team packed with prominent industry leaders. 28 October 2024
Biotechnology
Biostar Pharmaceuticals has announced its upcoming initial public offering (IPO) on the Hong Kong Stock Exchange, aiming to raise funds to advance its growing oncology pipeline and support its global expansion efforts. 25 October 2024
Biotechnology
Belgian biotech Agomab Therapeutics today announced a $89 million (82.1 million euros) Series D financing round, with participation from new investors Sanofi and Invus 25 October 2024
Pharmaceutical
Alpha-9 Oncology, a Canadian radiopharmaceutical company, has raised $175 million in an oversubscribed series C financing round led by Lightspeed Venture Partners and Ascenta Capital. 24 October 2024
Biotechnology
US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was led by global life sciences investor Novo Holdings. 23 October 2024
Biotechnology
Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in along with its launch in April. 21 October 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
LaNova Medicines, a Shanghai-based biopharma company, has announced that it has secured 3 billion yuan ($41 million) in its series C funding round. 18 October 2024
Biotechnology
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of $120 million. 18 October 2024
Pharmaceutical
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
Pharmaceutical
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
Pharmaceutical
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
Pharmaceutical
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Biotechnology
In Cambridge, UK, the protein specialist Nuclera has raised $75 million in a funding round led by Elevage Medical Technologies and backed by Patient Square Capital. 16 October 2024
Biotechnology
Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners. 16 October 2024
Biotechnology
In Hong Kong, Akeso Biopharma has successfully raised $250 million through a share placement, marking its second major fundraising effort of 2024. 15 October 2024
Pharmaceutical
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Boston, USA-based Upstream Bio, a biotech developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, has made an impressive start to life as a public-listed company.00000 14 October 2024
Pharmaceutical
Private investment platform Blackstone Life Sciences and Novartis have launched Anthos Therapeutics, a biopharma focused on cardiovascular (CV) disease. 28 February 2019
Biotechnology
China’s Gracell Biotechnologies has completed its $85 million series B funding. 27 February 2019
Biotechnology
Austria-based clinical stage biotech Hookipa Pharma, which is developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, says it has completed a $37.4 million series D financing. 26 February 2019
Pharmaceutical
Looking back over 2018, it is clear that the year was one of contrasts for biopharma companies, according to a new report from the Evaluate group and its editorial arm Vantage. 26 February 2019
Pharmaceutical
In the wake of its takeover of Shire, Japanese drugmaker Takeda (TYO: 4502) has announced it has filed paperwork for the issuance of a 500 billion yen ($4.5 billion) bond. 15 February 2019
Biotechnology
Immuno-oncology company Vor Biopharma has announced a $42 million Series A financing round. 15 February 2019
Biotechnology
The USA lobby group Biotechnology Innovation Organization (BIO) released a new report, “Science or Compliance: Will Section 404(b) Compliance Impede Innovation by Emerging Growth Companies in the Biotech Industry?” on Monday, coinciding with National Inventor’s Day. 12 February 2019
Biotechnology
A new company with 7.8 million Swiss francs ($7.8 million) in funding has been created to take forward an asset from private biopharma Aurealis Pharma. 11 February 2019
Pharmaceutical
Sanofi, UCB and leading US insurer BlueCross BlueShield are among the new strategic shareholders in Aetion, a tech company with a real-world analytics and evidence platform to engage in value-based care. 5 February 2019
Biotechnology
Japanese biotech Sosei Heptares Group has announced an agreement with Medicxi, a venture fund dedicated to financing asset-centric firms, to form two independent companies, Orexia and Inexia. 4 February 2019
Pharmaceutical
New Jersey, USA-based Rafael Holdings has bought a majority stake in Rafael Pharmaceuticals, building on prior investments in the metabolic oncology-therapeutics firm. 24 January 2019
Biotechnology
The leading trade group for the British biotech industry - the UK BioIndustry Association (BIA) - has published new figures showing that the sector raised a record £2.2 billion ($2.9 billion) last year, up from the £1.2 billion it raised in 2017. 24 January 2019
Pharmaceutical
Japanese drugmaker Takeda is said to be considering a sale of certain therapies in emerging markets, with the aim of reducing its debt burden in the wake of its $62 billion purchase of rare disease specialist Shire. 22 January 2019
Biosimilars
Privately-held Icelandic biopharmaceutical company Alvotech announced today that it has successfully raised $300 million through a private bond offering. 22 January 2019
Generics
India’s Caplin Point Laboratories today announced a 2.18 billion rupees ($30.7million) investment in its injectables subsidiary, Caplin Steriles, by Eight Roads Ventures. 21 January 2019
Pharmaceutical
Japan’s Takeda Pharmaceutical has announced the formal completion of its $62 billion acquisition of the rare disease specialist Shire. 8 January 2019
Biotechnology
Members of the deals team at Arix Bioscience, a London-listed venture capital (VC) firm specializing in biotech, are so well-connected that they will never lack for new innovations to invest in. 4 January 2019
Biotechnology
German immunotherapeutics specialist BioNTech has extended its research collaboration with French pharma major Sanofi initiated in late 2015. 4 January 2019
Pharmaceutical
Oculis has successfully raised a further 15.5 million Swiss francs ($15.8 million) in an extension of its Series B financing round, announced in January 2018, bringing the total raised to 35.5 million francs. 4 January 2019
Biotechnology
A third company has been launched by the USA-based orphan drug accelerator, Cydan. 3 January 2019
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze